Evidence map›Paper›PMID 32290394›Full record

ArticleInternational journal of molecular sciences2020

Virginia Sara Grancieri do Amaral, Stephanie Alexia Cristina Silva Santos, Paula Cavalcante de Andrade, Jenifer Nowatzki, Nilton Silva Júnior, Luciano Neves de Medeiros, Lycia Brito Gitirana, Pedro Geraldo Pascutti, Vitor H Almeida, Robson Q Monteiro and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. KI17: A Bioinspired Peptide Derived fromMolecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. The antimicrobial activity of ETD151 defensin is dictated by the presence of glycosphingolipids in the targeted organisms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Frontiers in oncology · 2023
    Article
  8. Antimicrobial Peptides with Anti-International journal of molecular sciences · 2022
    Review
  9. Review
  10. Characterization ofFrontiers in molecular biosciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Virginia Sara Grancieri do AmaralInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Stephanie Alexia Cristina Silva SantosInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.ORCID 0000-0003-3495-6302
Paula Cavalcante de AndradeInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Jenifer NowatzkiInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Nilton Silva JúniorInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Luciano Neves de MedeirosInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Lycia Brito GitiranaInstituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.ORCID 0000-0002-5580-6939
Pedro Geraldo PascuttiInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Vitor H AlmeidaInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.ORCID 0000-0002-2789-7116
Robson Q MonteiroInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.ORCID 0000-0002-5260-2332
Eleonora KurtenbachInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
Universidade Federal do Rio de Janeiro · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 429583/2016-8 (E.K.) and 309946/2018-2 (R.Q.M.)Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro 26/203.059/2017 (E.K.) and E-26/202.871/2018 (R.Q.M.).
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisBiopsyCell LineCell Membrane PermeabilityCell ProliferationDefensinsDisease Models, AnimalFemaleFluorescent Antibody TechniqueGlucosylceramidesImmunohistochemistryLung NeoplasmsMelanoma, ExperimentalMiceAntineoplastic Agents, Phytogenicdefensin 1, Pisum sativumDefensinsGlucosylceramidesPlant Proteinsanti-metastatic activitycyclin Fglucosylceramide (GlcCer)metastasis model of B16F10 melanomaPisum sativum defensin 1 (Psd1)

Identifiers

PMID32290394
PMCPMC7219108
OpenAlexW3016045164

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.